elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
Pricing
Log in
Sign up
Home
/
Subjects
/
Epithelial ovarian cancer
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Epithelial ovarian cancer
RIS
0.005
(Research Intensity Score)
Papers
339
Top papers
Clinical and translational advances in ovarian cancer therapy
2023 · 375 citations
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 · 378 citations
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update
2025 · 84 citations
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
2019 · 1480 citations
SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells
2022 · 257 citations
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
2021 · 296 citations
Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer
2022 · 131 citations
ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
2021 · 205 citations
Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18)
2025 · 39 citations
Newest papers
Chemoresistance in ovarian cancer (I)
2026 · 8 citations
Immunology and therapeutic strategies in ovarian cancer
2026 · 4 citations
Chemoresistance in gynecologic cancers: mechanistic insights and emerging platforms to overcome drug failure
2026 · 3 citations
Mocertatug rezetecan (GSK5733584), a B7-H4-targeted antibody-drug conjugate (ADC), in platinum-resistant ovarian cancer (PROC) and endometrial cancer (EC): First results from the global BEHOLD-1 study
2026 · 3 citations
Secondary cytoreductive surgery (S-CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent ovarian cancer: Current evidence and clinical perspectives
2026 · 3 citations
Mirvetuximab Soravtansine: Mechanism of Action, Clinical and Translational Science
2026 · 3 citations
Cell-intrinsic and tumor microenvironmental determinants of platinum resistance in epithelial ovarian cancer
2026 · 1 citations
Tumor stroma ratio-based radiomics model for predicting platinum resistance and prognosis in epithelial ovarian cancer
2026 · 1 citations
The phosphoproteome of ovarian carcinoma delineates signaling signatures and potentially druggable targets across histotype stages
2026
Browse all papers →
Epithelial ovarian cancer's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Epithelial ovarian cancer's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link